Effect of a herbal medicine in hypothyroidism
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: E039- Hypothyroidism, unspecifiedHealth Condition 2: E039- Hypothyroidism, unspecified
- Registration Number
- CTRI/2021/03/032428
- Lead Sponsor
- Anand P K V
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Known cases and newly determined cases of Hypothyroidism.
In between the age group of 18-60 years.
Serum TSH level more than 4.5 to 20 IU/ mL
Exclusion Criteria
Female patients who are pregnant.
Known cases of any congenital anomaly.
BMI more than 30
Patients with post thyroidectomy status, ischemic heart disease, uncontrolled hypertension, myocardial infarction, cerebrovascular event, cardiac arrhythmias and active malignant diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of polyherbal formulations in managing hypothyroidism symptoms?
How does the polyherbal formulation in CTRI/2021/03/032428 compare to levothyroxine in improving quality of life for hypothyroid patients?
Are there specific biomarkers that correlate with response to polyherbal treatment in hypothyroidism phase II trials?
What are the potential adverse events associated with polyherbal formulations in hypothyroidism management and how are they managed?
What are the key components of the polyherbal formulation in CTRI/2021/03/032428 and how do they synergize with standard hypothyroidism therapies?